Anadolu Medical Center
Anadolu Medical Center
Turkey, Istanbul
Zafer Gulbas
49 years of experience • 3315+ treatments performed
accreditations :
Clinic is certified :
Hodgkin's lymphoma treatment cost in Turkey typically ranges from $2,400 to $3,800 for chemotherapy, while essential diagnostics like a PET-CT scan can run from $100 to $200 for specialized consultations. Total expenses depend on the cancer stage, the number of therapy cycles, and the hospital's infrastructure. Patients generally save 40-60% compared to healthcare costs in the United States. Top cities for this treatment include Istanbul, Antalya, and Ankara.
Typical Hodgkin's Lymphoma Treatment Costs in Turkey
Bookimed Expert Insight: For complex or relapsed cases, multidisciplinary centers like Anadolu Medical Center provide superior value. They are official Johns Hopkins partners and house Turkey’s largest bone marrow transplant center. Professor Zafer Gulbas has performed over 3,000 transplants with an 81% autologous success rate. Advanced facilities like Memorial Goztepe offer the latest 512-slice CT and digital PET/CT for precise staging.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Chemotherapy | from $2,430 | from $2,500 | from $2,500 |
| Biological therapy | from $5,500 | from $20,000 | from $15,000 |
| Immunotherapy with Keytruda (Pembolizumab) | from $3,300 | from $15,000 | from $15,000 |
Prof. MD Zafer Gulbas has performed 900+ procedures for Hodgkin's lymphoma and founded the Bone Marrow Transplantation Center at Anadolu.
Dr. Bülent Karagöz specializes in tumor biology and immunotherapy, bringing over 33 years of experience of focused expertise to Hodgkin's lymphoma treatment at Anadolu Medical Center.
Prof. Sevindik has published 18 articles in international peer-reviewed journals and presented 26 abstracts at global conferences.
Professor Bulent Eser specializes in hematology with over 36 years of experience of experience in treating Hodgkin’s lymphoma. He works at Medical Park Antalya Hospital Complex.
Hodgkin lymphoma treatment in Turkey achieves a 90% 5-year survival rate for standard cases. Specialized centers report a 79.4% survival rate for relapsed conditions. Turkish hematologists utilize JCI-accredited facilities and international protocols like ABVD and immunotherapy to maintain these high efficacy standards.
Bookimed Expert Insight: Success in Turkey is driven by high-volume bone marrow centers. Anadolu Medical Center alone serves 65,000 patients yearly and is affiliated with Johns Hopkins. This clinical depth allows surgeons to maintain an 81% success rate specifically for autologous transplants. Look for centers with ESMO-certified oncologists like those at Gayrettepe Florence Nightingale Hospital to ensure global protocol compliance.
Patient Consensus: Patients often mention that hospital rooms feel like spacious suites with modern amenities. Many note that the clinical results are excellent and the medical teams inspire confidence during recovery.
Evidence-based treatment for Hodgkin lymphoma in Turkey follows international ESMO and NCCN guidelines. Protocols prioritize ABVD-based chemotherapy and PET-CT staging to determine therapy intensity. JCI-accredited centers like Anadolu Medical Center use tumor boards to coordinate chemotherapy, involved-site radiotherapy, or autologous stem cell transplants.
Bookimed Expert Insight: Turkish hematology centers offer high-level expertise at accessible rates, such as chemotherapy consultations starting around $2,700 at Gayrettepe Florence Nightingale. Specialists like Prof. Sezer Saglam and ESMO-certified Dr. Yesim Yildirim align local care with global standards. This combination of academic credentials and lower entry costs makes Istanbul a major hub for complex lymphoma care.
Patient Consensus: Patients note that getting a pathology review from lymphoma experts is vital to avoid misclassification. Many emphasize discussing fertility preservation before starting chemotherapy, especially for younger adults undergoing intensive regimens.
Inpatient stays for autologous stem-cell transplants in Turkey typically last between 14 and 28 days. This duration encompasses high-dose conditioning chemotherapy, the stem-cell infusion, and the critical engraftment phase. Patients remain hospitalized until their absolute neutrophil count reaches safe levels to prevent infections.
Bookimed Expert Insight: Data suggests choosing high-volume centers significantly impacts efficiency. Dr. Zafer Gulbas at Anadolu Medical Center has performed over 1,500 transplants and reports an 81% success rate specifically for autologous procedures. Experienced teams like his often manage the engraftment phase more predictably, which can prevent unexpected extensions to the 3-week stay.
Patient Consensus: Patients note the transplant day is surprisingly quick, but the real challenge is the wait for blood counts to recover. Many recommend preparing for a full 4-week stay just in case low counts or minor fevers delay the release date.
Turkish oncology centers provide comprehensive English-language support through dedicated international patient departments. Facilities like Anadolu Medical Center employ professional interpreters and personal coordinators. These services ensure clear communication during complex Hodgkin's lymphoma consultations, diagnostic procedures, and multi-cycle chemotherapy sessions.
Bookimed Expert Insight: Anadolu Medical Center stands out for English support because of its direct JCI-accredited partnership with Johns Hopkins Medicine. Their high volume of over 65,000 annual patients creates a highly standardized environment for English-language medical terminology and international patient care protocols.
Patient Consensus: Patients note that while many doctors speak English, it is essential to request written English copies of chemotherapy protocols and prescriptions before leaving the hospital.